NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+25.16%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.46B
AUM Growth
+$1.46B
(+11%)
Cap. Flow
-$9.7M
Cap. Flow
% of AUM
-0.66%
Top 10 Holdings %
Top 10 Hldgs %
25.13%
Holding
226
New
28
Increased
57
Reduced
41
Closed
25
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$31.6M |
| 2 |
Merck
MRK
|
$28.3M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
$23.7M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$23.1M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$13.6M |
Top Sells
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$29.3M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$28.4M |
| 3 |
United Therapeutics
UTHR
|
$26.8M |
| 4 |
Sarepta Therapeutics
SRPT
|
$25.8M |
| 5 |
Insulet
PODD
|
$23.6M |
Sector Composition
| 1 | Healthcare | 53.92% |
| 2 | Technology | 13.34% |
| 3 | Industrials | 8.74% |
| 4 | Consumer Discretionary | 4.85% |
| 5 | Energy | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lattice Semiconductor
LSCC
$9.16B
| $18.6M | 1.27% |
193,348
-16,088
| -8% | -$1.55M |
|
27
Exxon Mobil
XOM
$477B
| $17.5M | 1.2% |
163,000
| – | – |
|
28
CACI
CACI
$10.3B
| $17.3M | 1.18% |
50,791
+981
| +2% | +$334K |
|
29
Alnylam Pharmaceuticals
ALNY
$58.6B
| $17.2M | 1.17% |
90,351
| – | – |
|
30
Celsius Holdings
CELH
$15.8B
| $16.5M | 1.13% |
110,646
-14,687
| -12% | -$2.19M |
|
31
Iridium Communications
IRDM
$2.62B
| $16.1M | 1.1% |
259,622
+44,968
| +21% | +$2.79M |
|
|
CHX
32
DELISTED
ChampionX
CHX
| $15.7M | 1.07% |
505,756
+16,676
| +3% | +$518K |
|
33
Ascendis Pharma
ASND
$12.1B
| $15.2M | 1.04% |
170,609
-80,778
| -32% | -$7.21M |
|
34
TFI International
TFII
$7.92B
| $14.9M | 1.02% |
130,996
-25,497
| -16% | -$2.91M |
|
35
Fluence Energy
FLNC
$884M
| $14.1M | 0.97% |
530,662
+475,301
| +859% | +$12.7M |
|
36
Symbotic
SYM
$5.06B
| $13.9M | 0.95% |
325,321
-80,248
| -20% | -$3.44M |
|
37
Microsoft
MSFT
$3.76T
| $12.8M | 0.88% |
37,694
+8,594
| +30% | +$2.93M |
|
|
ISEE
38
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $12.8M | 0.88% |
+325,548
| New | +$12.8M |
|
39
Chevron
CVX
$318B
| $12.8M | 0.88% |
81,350
| – | – |
|
40
Broadcom
AVGO
$1.42T
| $11M | 0.75% |
12,651
| – | – |
|
41
Taylor Morrison
TMHC
$6.67B
| $10.7M | 0.73% |
219,637
+564
| +0.3% | +$27.5K |
|
42
NVIDIA
NVDA
$4.15T
| $10.4M | 0.71% |
24,682
-85
| -0.3% | -$36K |
|
43
Biohaven
BHVN
$1.71B
| $10.2M | 0.7% |
425,000
-475,270
| -53% | -$11.4M |
|
44
ArcBest
ARCB
$1.65B
| $9.44M | 0.65% |
95,555
+448
| +0.5% | +$44.3K |
|
45
Ares Management
ARES
$38.8B
| $9.26M | 0.63% |
96,105
| – | – |
|
46
MGIC Investment
MTG
$6.47B
| $8.97M | 0.61% |
568,202
+316,684
| +126% | +$5M |
|
47
Super Micro Computer
SMCI
$23.8B
| $8.13M | 0.56% |
+32,634
| New | +$8.13M |
|
48
Evercore
EVR
$12.1B
| $8M | 0.55% |
64,691
+21,266
| +49% | +$2.63M |
|
49
Wingstop
WING
$9.01B
| $7.94M | 0.54% |
39,649
-16,950
| -30% | -$3.39M |
|
|
CBAY
50
DELISTED
Cymabay Therapeutics
CBAY
| $7.63M | 0.52% |
+696,947
| New | +$7.63M |
|